5mg

SLU-PP-332 (SLU)

5mg

120.00$

SLU-PP-332 is researched for its potential influence on energy expenditure and mitochondrial activity pathways. Studies explore its role in endurance-related metabolic signaling and cellular energy output models.

SLU-PP-332 (SLU)

Product Name: SLU-PP-332 (SLU)
Type: Metabolic Activation Research Compound

Research Focus:

PRECLINICAL RESEARCH COMPOUND: SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ) studied exclusively in murine models for its ability to activate an aerobic-exercise gene program, enhance mitochondrial function, and improve endurance and cardiometabolic phenotypes[1][2][3]. No human trials have been conducted as of November 2025. This educational protocol reflects published murine regimens using intraperitoneal administration.

 

Research Interest:

  • Endurance and performance signaling research

  • Mitochondrial activation pathway studies

  • Energy expenditure regulation models

  • Metabolic efficiency signaling networks

 

Scientific Interest:

  • Cellular oxidative capacity regulation

  • Substrate utilization signaling pathways

  • Mitochondrial biogenesis research


Reconstitution:

  • Evidence Base: Preclinical only—in vivo mouse studies with intraperitoneal dosing (25–50 mg/kg twice daily).

  • Reconstitute: Add 3.0 mLbacteriostatic water → ~1.67 mg/mLconcentration.

  • Murine dose range: 1250–2500 mcgdaily (for a 25 g mouse), administered in two divided doses.

  • Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U-100 insulin syringe.

  • Storage: Lyophilized: −20 °C (−4 °F); reconstituted: 2–8 °C (35.6–46.4 °F).

Cycle:


Murine-Equivalent Protocol (3 mL = ~1.67 mg/mL)

PHASE

DAILY DOSE (MCG)

PER-INJECTION DOSE (MCG)

UNITS PER INJECTION (ML)

Weeks 1–2

1250 mcg

625 mcg

37.5 units (0.375 mL)

Weeks 3–8

2500 mcg

1250 mcg

75 units (0.75 mL)


Route & Frequency:
Published murine studies used intraperitoneal administration twice daily (25–50 mg/kg)[1][2][3]. Daily mcg values above are expressed for a 25 g mouse. No reputable sources support once-daily subcutaneous use for this compound.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

  2. Inject slowly down the vial wall; avoid foaming.

  3. Gently swirl/roll until dissolved (do not shake).

  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.




IMPORTANT NOTICE:

This product is intended strictly for laboratory research and is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease.

King St. West,
Toronto, Ontario
Canada.

M6K 3M3